1st Annual Meeting of the Chinese-German Society for Translational Medicine

CDGTM 1st Annual Meeting – July 23-24, 2022.

We invite you to join us at the 1st Annual Meeting of the Chinese-German Society for Translational Medicine (Chinesisch-Deutsche Gesellschaft für Translationale Medizin e.V.) on July 23-24, 2022 in Tuebingen, Germany!
The theme of this year is “Progress and Technical Translation in the field of Brain- and Neuroscience”. The meeting will bring together clinical doctors and neuroscientists from both academia and industry to discuss the latest breakthroughs in the study of brain- and neurscience. Numerous new technological innovations emerges in the recent years, such as super-resolution microscopy, tissue clearing, genome editing, and single-cell sequencing have empowered the research of brain and nervous systems at unprecedented levels. Discussions will be encouraged both in the scientific sessions as well as the time during coffee breaks and after-meeting for more interactions. Our major goal of this international meeting will be to provide a chance for interactions among scientists from different backgrounds and all levels in order to stimulate new collaborations and even new directions in brain and neuroscience research. To support the next generation of neuroscientists, besides talks from distinguished scientists in this field, short talks and posters will be selected from abstracts submitted by young scientists and students. This meeting will also feature an informal session for all attendees to discuss the challenges in sciences to translate effectively which most scientists in the biomedical field face nowadays.
This year, we are honored to hold our 1st annual meeting with our close cooperator Peking University. This cooperation is honorably promoted by Prof. Hongbin Han, the president of the Institute of Medical Technology at Peking University, the honored president of CDGTM.

Keynote speaker this year!
Prof. Jianwei Zhang
Jianwei Zhang is Professor and Director of TAMS, Department of Computer Science, University of Hamburg, Germany. He received both his Bachelors (1986, with honors) and Masters of Engineering (1989) from the Faculty of Computer Science, Tsinghua University, Beijing, China. He received his PhD (1994) from the Institute for Real-Time Systems and Robotics, Faculty of Computer Science, University of Karlsruhe, Germany. His research interests are in the areas of sensor fusion, intelligent robotics, and multimodal machine learning, among others. In these areas, he has published about 500 journal and conference papers, technical reports, and four books. He is the coordinator of the DFG/NSFC Transregio Collaborative Research Center SFB/TRR169 “Crossmodal Learning” and some EU projects for robotics. He has received several awards for his papers. He is the chair of IEEE MFI 2012, IEEE/RSJ IROS 2015 and International Symposium of Human-Centered Robotics and Systems 2018, etc. Jianwei Zhang is a full member of the German Academy of Science and Engineering and the Academy of Sciences in Hamburg. Prof. Zhang is also chairman of the Association of Chinese in Northern Germany e.V. and the Tsinghua Alumni Association in Germany.

Prof. Peter Dayan
Peter Dayan FRS is director at the Max Planck Institute for Biological Cybernetics in Tübingen, Germany. He is co-author of Theoretical Neuroscience, an influential textbook on computational neuroscience. He is known for applying bayesian methods from machine learning and artificial intelligence to understand neural function and is particularly recognized for relating neurotransmitter levels to prediction errors and Bayesian uncertainties. He has pioneered the field of reinforcement learning (RL) where he helped develop the Q-learning algorithm, and made contributions to unsupervised learning, including the wake-sleep algorithm for neural networks and the Helmholtz machine. Dayan was elected a Fellow of the Royal Society (FRS) in 2018. He was awarded the Rumelhart Prize in 2012 and The Brain Prize in 2017.

Prof. Zhaoping Li
Li Zhaoping,born in Shanghai, China, is a neuroscientist at the University of Tübingen in Germany. Li Zhaoping, together with Geoffrey Hinton and Peter Dayan, co-founded the Gatsby Computational Neuroscience Unit in University College London. Currently, Li Zhaoping is a professor at the University of Tübingen. She is also the head of the department of Sensory and Sensorimotor Systems in Max Planck Institute for Biological Cybernetics. She is known as the creator of the V1 Saliency Hypothesis, V1SH (pronounced ‘vish’), that the primary visual cortex (V1) in primates creates a saliency map of the visual field to guide visual attention or gaze shifts exogenously. She is the author of Understanding vision: theory, models, and data published by Oxford University Press.

*Prof. Sebastian Jessberger
Sebastian Jessberger is Professor for Neurosciences and Director of the Brain Research Institute. He studied Medicine in Hamburg, Germany and carried out his medical thesis at the Center for Molecular Neurobiology (ZMNH) in Hamburg. In 2002 he started a joint residency in the laboratory of Gerd Kempermann at the Max Delbruck Center for Molecular Medicine (MDC) and the Dept. of Neurology of the Charité University Hospital in Berlin, Germany. As a postdoctoral fellow (2004-2007) in the laboratory of Fred H. Gage at the Salk Institute for Biological Studies in La Jolla, USA he continued to work on neural stem cell biology and neurogenesis in the adult brain. From 2007 to 2012 he was Assistant Professor at the ETH Zurich and joined the Brain Research Institute in August 2012. He is a fellow of the MaxnetAging network of the Max Planck Society, received several prizes (e.g., Friedrich Götz prize 2013, Robert Bing prize 2016) and was awarded to join the EMBO Young Investigator program in 2012. He received an ERC Consolidator Grant in 2016.

About CDGTM
The purpose of CDGTM is to promote science, application, and cooperation in the fields of medicine, biology, physiology, and related fields and to serve scientific, technical, and economic progress in these fields. The purpose of the statutes is achieved in particular through the organization of annual meetings, specialist conferences, seminars, and other functional events; promotion and strengthening of communication and cooperation between scientists, especially biologists and translational medical professionals; promotion of cooperation and collaboration with scientific, in particular institutions, associations and industrial companies in China and in the Federal Republic of Germany; promotion and support of the mutual exchange of information and experience as well as the cooperation between China and the Federal Republic of Germany in the fields of translational medicine and biology.
More information can be found at our official website http://www.cdgtm.org.

About Institute of Medical Technology at Peking University
Institute of Medical Technology at Peking University is newly founded in the year 2019. Being an institute in the 1st ranking university in China – Peking University, the driving force of the development of medical technology discipline is to tackle the problem appearing in the clinical diagnosis and treatment of major diseases and the demand for the independent innovation and development of domestic medical equipment industry. Supported by the science and engineering discipline of Peking University and many other universities, Institute of Medical Technology had jointly undertaken a number of special projects concerning major medical equipment and developed a graduate course of advanced medical technology. The institute would always support the innovative development of interdisciplinary research of medicine and technology.

About CDGTM Annual Meeting
Each year the Chinese-German Society for Translational Medicine will hold an annual meeting in the summer with different popular themas in medicial and life science field. The purpose of the meeting is to bring together researchers from around the world to share the latest and attractful studies in biomedicine and life sciences which has the potential for translation into the industry field. This 2-day event is filled with keynote addresses, talks, posters, awards, invited symposia, and most importantly the opportunity to connect with distinguished scientists in the field of translational medicine.